This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.70% per year. These returns cover a period from January 1, 1988 through April 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
medical-devices: Archive
Intuitive Surgical Trades Near 2-Year Low: Is $600 Within Reach?
by Indrajit Bandyopadhyay
ISRG nears a key support level after a 23.7% YTD drop, but strong da Vinci 5 adoption and procedure growth may fuel a rebound.
MDTPositive Net Change SYKPositive Net Change ISRGNegative Net Change
medical medical-devices
NXP Semiconductors (NXPI)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
NXPIPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Abbott Stock at 52-Week Low After Q1 Earnings: Book Profits or Hold?
by Moumi Mondal
ABT's Q1 beat was overshadowed by Exact Sciences dilution, legal risks and weak Diagnostics trends as shares hit a 52-week low.
ABTNegative Net Change MDTPositive Net Change TNDMNegative Net Change
medical medical-devices
TFX Stock Down Post Q1 Earnings & Revenue Beat, Margins Crash
by Zacks Equity Research
Teleflex beats Q1 earnings and revenue estimates, but steep margin declines and a 52.1% drop in operating profit pressure shares.
LHPositive Net Change ISRGNegative Net Change TFXPositive Net Change BTSGPositive Net Change
earnings medical medical-devices
Do Options Traders Know Something About GE Healthcare Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to GEHC stock based on the movements in the options market lately.
GEHCNegative Net Change
medical medical-devices
GE HealthCare Expands SIGNA MR Portfolio With AI-Powered Tools
by Zacks Equity Research
GEHC unveils AI-powered MRI innovations at ISMRM 2026, expanding imaging speed, quality and research collaboration tools.
ISRGNegative Net Change WSTPositive Net Change GMEDPositive Net Change GEHCNegative Net Change
medical medical-devices
3 Highly Ranked Medical Stocks to Buy Now: DVA, GMED, PGNY
by Shaun Pruitt
These highly ranked medical stocks have been capitalizing on their sales expansion, and their defensive or secular growth profiles could become even more attractive if an economic downturn emerges.
DVANegative Net Change MEDNegative Net Change PGNYPositive Net Change
earnings hospitals investing medical medical-devices
GEHC Launches MIM ComboTherapy for GYN Cancer Radiation Planning
by Zacks Equity Research
GE HealthCare launches MIM ComboTherapy to improve radiation planning for gynecologic cancers with advanced dose visualization.
ISRGNegative Net Change WSTPositive Net Change GMEDPositive Net Change GEHCNegative Net Change
medical medical-devices
Urogen Pharma (URGN) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
URGNNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
AUNA Q1 Earnings Preview: How Should You Play the Stock Now?
by Moumi Mondal
AUNA S.A. heads into May 19 Q1 results with a flat EPS outlook and 8%+ revenue growth expected, but weak signals from Mexico and mixed regional trends cloud sentiment.
THCNegative Net Change PGNYPositive Net Change AUNANegative Net Change
earnings-preview medical medical-devices